2013
DOI: 10.1021/mp4005029
|View full text |Cite
|
Sign up to set email alerts
|

Formulation and Characterization of Nanoemulsion Intranasal Adjuvants: Effects of Surfactant Composition on Mucoadhesion and Immunogenicity

Abstract: Development of effective intranasal vaccines is of great interest due to their potential to induce both mucosal and systemic immunity. Here we produced oil-in-water nanoemulsion (NE) formulations containing various cationic and nonionic surfactants for use as adjuvants for the intranasal delivery of vaccine antigens. NE induced immunogenicity and antigen delivery are believed to be facilitated through initial contact interactions between the NE droplet and mucosal surfaces which promote prolonged residence of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
55
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 62 publications
(56 citation statements)
references
References 40 publications
1
55
0
Order By: Relevance
“…In this regard it is interesting to note that the oil-free formulation of ID93+GLA was as immunogenic and protective in the present study as the emulsion-based formulation. While no safety concerns have been reported with oil-in-water emulsion based intranasal formulations [31], the aqueous suspension formulation of GLA contains much less excipient content, thereby reducing manufacturing cost as well as the potential for any reactogenicity due to the oil and emulsifier excipients present in the emulsion. Moreover, previous reports of intranasally administered aqueous suspension of the TLR4 ligand MPL have shown promising safety and immunogenicity results in preclinical and clinical testing [32-34].…”
Section: Discussionmentioning
confidence: 99%
“…In this regard it is interesting to note that the oil-free formulation of ID93+GLA was as immunogenic and protective in the present study as the emulsion-based formulation. While no safety concerns have been reported with oil-in-water emulsion based intranasal formulations [31], the aqueous suspension formulation of GLA contains much less excipient content, thereby reducing manufacturing cost as well as the potential for any reactogenicity due to the oil and emulsifier excipients present in the emulsion. Moreover, previous reports of intranasally administered aqueous suspension of the TLR4 ligand MPL have shown promising safety and immunogenicity results in preclinical and clinical testing [32-34].…”
Section: Discussionmentioning
confidence: 99%
“…[4][5][6][7] The studies in various solvent mixtures are relevant for the improvement of surfactant micellisation properties to enhance their performances since properties of the solutions can be optimised for various industrial formulations and commercial applications. [8][9][10][11] It is well established that the self-association of surfactants is governed by the intricate balance between the hydrophobic interaction and other types of non-covalent solute-solute and solute-solvent interactions. [12] The presence of polar organic solvent as an additive can significantly influence the micellisation thermodynamic properties of an ionic surfactant in water.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the promising results of in vitro and animal studies, the application of nanoemulsions for nasal delivery in humans appears to be hindered mainly by the lack of detailed toxicology studies and the lack of extensive clinical trials [198]. A cationic nanoemulsion formulation could have facilitated cellular uptake of model antigen ovalbumin in the nasal epithelial cell line [199]. The intranasal vaccination of HIV gp120 immunogen formulated in oil-inwater nanoemulsions induced robust serum anti-gp120 IgG and Th1-polarized systemic cellular immune responses [200].…”
Section: A Nanoemulsionsmentioning
confidence: 99%